Improved paracellular uptake by the combination of different types of permeation enhancers

被引:34
作者
Guggi, D
Bernkop-Schnürch, A
机构
[1] Leopold Franzens Univ, Inst Pharm, Dept Pharmaceut Technol & Biopharmaceut, A-6020 Innsbruck, Austria
[2] Univ Vienna, Ctr Pharm, Inst Pharmaceut Technol, A-1090 Vienna, Austria
关键词
proteases; bromelain; thiomers; permeation enhancement;
D O I
10.1016/j.ijpharm.2004.09.023
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study had the purpose to improve the paracellular uptake of drugs by combining the thiomer/reduced glutathione (GSH) permeation-enhancing system with a proteolytic enzyme. Due to the covalent binding of 2-iminothiolane to chitosan the thiomer chitosan-TBA (chitosan-4-thiobutylamidine) was obtained. Permeation studies were performed with freshly excised intestinal mucosa of guinea pigs mounted in Ussing-type chambers using on the one hand the low-molecular size marker flurescein (NaFlu) and on the other hand the high-molecular size marker FITC-dextran. Apparent permeability coefficient (P-app) as well as enhancement ratios (=P-app permeation-enhancing system/P-app control) were calculated. Trypsin, papain and bromelain displayed a permeation-enhancing effect for Na-Flu on the small intestinal mucosa. Enhancement ratios of 1.84, 1.63 and 1.78 were identified for 2% trypsin, 0.5% papain and 2% bromelain solutions, respectively. However, only bromelain could guarantee a significant permeation enhancement of FITC-dextran with a Papp of 4.45 +/- 0.44 x 10(-6) cm/s representing an enhancement ratio of 1.57. A similar enhancement of FITC-dextran permeation was reached by the use of the chitosan-TBA (0.5%)/GSH (5%) system. Moreover, an additive permeation-enhancing effect of the chitosan-TBA/GSH system in combination with bromelain (2%) was observed, leading to a maximum P-app of 5.91 +/- 0.51 x 10(-6) cm/s, which corresponds to an enhancement ratio of 2.1. According to these results, the combination of the thiomer/GSH system with bromelain might represent a new promising strategy in order to raise the in vivo efficacy of non-invasive administered hydrophilic macromolecular drugs. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 28 条
  • [11] Transport of proteolytic enzymes across Caco-2 cell monolayers
    Bock, U
    Kolac, C
    Borchard, G
    Koch, K
    Fuchs, R
    Streichhan, P
    Lehr, CM
    [J]. PHARMACEUTICAL RESEARCH, 1998, 15 (09) : 1393 - 1400
  • [12] The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption .3. Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
    Borchard, G
    Luessen, HL
    deBoer, AG
    Verhoef, JC
    Lehr, CM
    Junginger, HE
    [J]. JOURNAL OF CONTROLLED RELEASE, 1996, 39 (2-3) : 131 - 138
  • [13] CALICETI P, 2003, P INT S CONTR REL BI, V30, P677
  • [14] The role of glutathione in the permeation enhancing effect of thiolated polymers
    Clausen, AE
    Kast, CE
    Bernkop-Schnürch, A
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (05) : 602 - 608
  • [15] Clausen AE, 2000, J PHARM SCI-US, V89, P1253, DOI 10.1002/1520-6017(200010)89:10<1253::AID-JPS3>3.0.CO
  • [16] 2-8
  • [17] Thiolated carboxymethylcellulose:: in vitro evaluation of its permeation enhancing effect on peptide drugs
    Clausen, AE
    Bernkop-Schnürch, A
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2001, 51 (01) : 25 - 32
  • [18] EMELE JF, 1966, ARCH INT PHARMACOD T, V159, P126
  • [19] In vivo evaluation of an oral salmon calcitonin-delivery system based on a thiolated chitosan carrier matrix
    Guggi, D
    Kast, CE
    Bernkop-Schnürch, A
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (12) : 1989 - 1994
  • [20] Systemic peptide delivery via the stomach:: in vivo evaluation of an oral dosage form for salmon calcitonin
    Guggi, D
    Krauland, AH
    Bernkop-Schnürch, A
    [J]. JOURNAL OF CONTROLLED RELEASE, 2003, 92 (1-2) : 125 - 135